glp-1 for obesity kenner Who should actually take a GLP-1? An expert's honest take | Levels Beyond GLP-1s: The next chapter

Cardiovascular Outcome Trials in Type 2 Diabetes CVOTs in T2D were designed primarily to establish cardiovascular safety in patients diagnosed with T2D who also have established cardiovascular disease (CVD) or have a high cardiovascular risk

(PubMed) Singh RB, Niaz MA, Kumar A, Sindberg CD, Moesgaard S, Littarru GP

Penetration of LDL into the artery wall occurs at branch points in the aorta and other places with turbulent flow and shear stress

Nevertheless, future larger trials are required to evaluate the robustness of the effects

It's loaded with good-for-the-skin things: it contains fatty acids , mainly oleic (35%), stearic (34%), and palmitic (25%) and it also has antioxidant vitamin E and polyphenols